2Gadducci A,Tana R,Cosio S,et al.The serum assay of tumourmarkers in the prognostic evaluationt,reatment monitoring and fol-low-up of patients with cervical cancer:a review of the literature[J].Crit Rev Oncol Hematol,2008,66(1):10-20.
3Yuan SH,Liang XFJ,ia WH,et al.Molecular diagnosis of sentinellymph node metastases in cervical cancer using squamous cell carci-noma antigen[J].Clin Cancer Res,2008,14(17):5571-5578.
4Kagohashi K,Satoh H,Kurishima K,et al.Squamous cell carcinomaantigen in lung cancer and nonmalignant respiratory diseases[J].Lung,2008,186(5):323-326.
5Trerotoli P,Fransvea E,Angelotti U,et al.Tissue expression of Squa-mous Cellular Carcinoma Antigen(SCCA)is inversely correlated totumor size in HCC[J].Mol Cancer,2009,27(8):29.
6Kosugi S,Nishimaki T,Kanda T,et al.Clinical significance of ser-um carcinoembryonic antigen,carbohydrate antigen 19-9,and squa-mous cell carcinoma antigen levels in esophageal cancer patients[J].World J Surg,2004,28(7):680-685.
7Mroczko B,Kozowski M,Groblewska M,et al.The diagnostic valueof the measurement of matrix metalloproteinase 9(MMP-9),squa-mous cell cancer antigen(SCC)and carcinoembryonic antigen(CEA)in the sera of esophageal cancer patients[J].Clin Chim Ac-ta,2008,389(1-2):61-66.
8Homma S,Harada M,Yano H,et al.Identification of squamouscell carcinoma antigen-derived peptides having the capacity of indu-cing cancer-reactive CTLs in HLA-A24+cancer patients[J].Int JOncol,2006,29(3):577-587.
9Gadducci A,Tana R,Fanucchi A,et al.Biochemical prognostic fac-tors and risk of relapses in patients with cervical cancer[J].GynecolOncol,2007,107(1 Suppl 1):23-26.
10Kim YT,Yoon BS,Kim JWe,t al.Pretreatment levels of serum squa-mous cell carcinoma antigen and urine polyamines in women withsquamous cell carcinoma of the cervix[J].Int J Gynaecol Obstet,20059,1(1):47-52.
